To investigate the molecular mechanisms by which IFN-signaling increases the steady-state levels of ERα mRNA and protein in mouse splenic cells, we investigated the effect of IFN-treatment of WT276 mouse breast cancer cell line (an ERα-positive cell line; ref. 31) on steady-state levels of ERα mRNA and protein. The gene discussed is IFNA1; the disease is breast cancer.